China's Nio to get near $740 million investment from Abu Dhabi-backed firm

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 18 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 66%

Nigeria News News

Nigeria Nigeria Latest News,Nigeria Nigeria Headlines

:CYVN Holdings, a firm backed by the Abu Dhabi government, will invest about $738.5 million in Nio Inc, the Chinese electric vehicle maker said on Tuesday, as it looks to bolster the company's balance sheet.Nio and peers Xpeng and Li Auto are among those competing to grab a larger EV market share in the world

:CYVN Holdings, a firm backed by the Abu Dhabi government, will invest about $738.5 million in Nio Inc, the Chinese electric vehicle maker said on Tuesday, as it looks to bolster the company's balance sheet.

Under the deal, Nio will issue about 85 million new Class A shares at $8.72 per share to CYVN Holdings.CYVN has also entered into a deal with an affiliate of Tencent Holdings, under which it will pick up some shares of Nio. Nio said it will pursue global business opportunities jointly with CYVN following the closing of the investment deal.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in NG
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Nigeria Nigeria Latest News, Nigeria Nigeria Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

AstraZeneca planning China business spin off: ReportDrugmaker AstraZeneca is drafting a plan to spin off its China business, and listing a separate unit in Hong Kong is being viewed as an option, the Financial Times reported on Sunday (Jun 18). A separation might not ultimately take place, the report said, citing people familiar with the matter, with one of
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

AstraZeneca planning China business spin off -FTDrugmaker AstraZeneca is drafting a plan to spin off its China business, and listing a separate unit in Hong Kong is being viewed as an option, the Financial Times reported on Sunday. 'A separation might not ultimately take place,' the report said, citing people familiar with the matter, with one of them
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »